Bora Pharmaceuticals Co., LTD. (6472.TW)
TWD 744.0
(-0.67%)
TWD 744.0
(-0.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 4.61 Billion | 2.01 Billion | 1.23 Billion | 177.79 Million | 231.77 Million |
| Net Income | 4.06 Billion | 1.84 Billion | 1.02 Billion | 595.39 Million | 305.03 Million |
| Depreciation & Amortization | 606.28 Million | 325.18 Million | 210.16 Million | 141.02 Million | 119.61 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 102.81 Million | 31.82 Million | 15.77 Million | 28.71 Million | 15.84 Million |
| Change in working capital | -491.93 Million | 4.3 Million | -50.16 Million | -198.31 Million | -211.3 Million |
| Other non-cash items | 116.68 Million | 113.97 Million | 53.39 Million | -366.84 Million | 2.59 Million |
| Investing Cash Flow | -2.45 Billion | -4.28 Billion | -225.84 Million | -1.53 Billion | -827.48 Million |
| Investments in PPE | -1.43 Billion | -200.21 Million | -363.58 Million | -152.09 Million | -697.33 Million |
| Acquisitions | -999.99 Million | -4.49 Billion | -3.83 Million | -1.38 Billion | -58.92 Million |
| Investment purchases | 53.64 Million | 323.98 Million | - | - | - |
| Sales/Maturities of investments | -95.35 Million | - | - | 67.35 Million | - |
| Other Investing Activities | 10.92 Million | 47.48 Million | 55.33 Million | -70.55 Million | -71.23 Million |
| Financing Cash Flow | -2.44 Billion | 4.59 Billion | -741.39 Million | 1.57 Billion | 551 Million |
| Debt repayment | -1.69 Billion | -4.44 Billion | -626.72 Million | -1.41 Billion | -431.58 Million |
| Dividends payments | -619.13 Million | -238.8 Million | -109.76 Million | -83.25 Million | -88.49 Million |
| Common Stock Repurchased | - | -53.09 Million | - | - | - |
| Common Stock Issuance | 33.93 Million | 3.89 Million | 66.9 Million | 271.1 Million | - |
| Other Financing Activities | 70.28 Million | 576.93 Million | -225 Thousand | 1.24 Billion | 1.51 Million |
| Accounts receivables | 2.15 Billion | -1.5 Billion | -282.38 Million | -217.98 Million | -137.45 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -124.49 Million | 99.38 Million | 172.37 Million | -190.92 Million | -99.76 Million |
| Other working capital | -2.56 Billion | 1.31 Billion | 33.67 Million | 49.26 Million | 25.91 Million |
| Cash at beginning of period | 3.28 Billion | 910.74 Million | 669.98 Million | 452.67 Million | 497.6 Million |
| Cash at end of period | 3.05 Billion | 3.28 Billion | 910.74 Million | 669.98 Million | 452.67 Million |
| Capital Expenditure | -1.43 Billion | -200.21 Million | -363.58 Million | -152.09 Million | -697.33 Million |
| Effect of forex changes on cash | 56.12 Million | 46.88 Million | -28.62 Million | 28 Thousand | -214 Thousand |
| Net cash flow / Change in cash | -228.02 Million | 2.37 Billion | 240.76 Million | 217.3 Million | -44.92 Million |
| Free Cash Flow | 3.18 Billion | 1.8 Billion | 873.05 Million | 25.69 Million | -465.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.51 Billion | 983.54 Million | 4.06 Billion | 679.65 Million | 923.01 Million | 1.01 Billion |
| Depreciation & Amortization | 251.62 Million | 191.35 Million | 606.28 Million | 184.27 Million | 150.57 Million | 137.75 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 26.49 Million | 43.75 Million | 102.81 Million | 46.41 Million | 17.65 Million | 21.32 Million |
| Change in working capital | -2.16 Billion | 26.28 Million | -491.93 Million | 12.45 Million | -546.18 Million | -398.4 Million |
| Other non-cash items | -669.82 Million | 29.22 Million | 116.68 Million | 22.56 Million | 31.17 Million | 24.87 Million |
| Investing Cash Flow | -9.41 Billion | -480.7 Million | -2.45 Billion | 36.76 Million | -1.22 Billion | -1.28 Billion |
| Investments in PPE | -133.83 Million | -201.34 Million | -1.43 Billion | -101.72 Million | -1.15 Billion | -109.42 Million |
| Acquisitions | -7.76 Billion | -1.39 Million | -999.99 Million | 288.42 Million | -61.63 Million | -1.22 Billion |
| Investment purchases | -1.74 Billion | -303.57 Million | 53.64 Million | 53.64 Million | - | -78.02 Million |
| Sales/Maturities of investments | 233.25 Million | 280.95 Million | -95.35 Million | -211.97 Million | -6.28 Million | 44.88 Million |
| Other Investing Activities | -3.75 Million | -260.85 Million | 10.92 Million | 8.39 Million | -1.84 Million | 5.8 Million |
| Financing Cash Flow | 8.8 Billion | 4.1 Billion | -2.44 Billion | -2.08 Billion | 247.99 Million | -156.22 Million |
| Debt repayment | -9.41 Billion | -4.06 Billion | -1.69 Billion | -2.05 Billion | -840.37 Million | -105.56 Million |
| Dividends payments | - | - | -619.13 Million | - | -619.13 Million | - |
| Common Stock Repurchased | -389.12 Million | - | - | - | - | - |
| Common Stock Issuance | 1.06 Million | 10.2 Million | 33.93 Million | 20.53 Million | 6.59 Million | 1.19 Million |
| Other Financing Activities | -100.05 Million | 83.28 Million | 70.28 Million | -3.26 Million | 74.41 Million | 14.06 Million |
| Accounts receivables | -1.46 Billion | -13.24 Million | 2.15 Billion | -77.07 Million | -472.08 Million | 1.62 Billion |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -43.21 Million | -225.48 Million | -124.49 Million | 243.14 Million | -333.05 Million | -186.49 Million |
| Other working capital | -156.99 Million | 261.44 Million | -2.56 Billion | -75.13 Million | 184.56 Million | -1.9 Billion |
| Cash at beginning of period | 8.06 Billion | 3.05 Billion | 3.28 Billion | 4.13 Billion | 4.2 Billion | 4.8 Billion |
| Cash at end of period | 5.5 Billion | 8.06 Billion | 3.05 Billion | 3.05 Billion | 4.13 Billion | 4.2 Billion |
| Capital Expenditure | -133.83 Million | -201.34 Million | -1.43 Billion | -101.72 Million | -1.15 Billion | -109.42 Million |
| Effect of forex changes on cash | 152.22 Million | 146.64 Million | 56.12 Million | -186.64 Million | 193.07 Million | 56.19 Million |
| Net cash flow / Change in cash | -2.55 Billion | 5.01 Billion | -228.02 Million | -1.08 Billion | -68.64 Million | -602.4 Million |
| Free Cash Flow | -2.22 Billion | 1.03 Billion | 3.18 Billion | 1.05 Billion | -438.77 Million | 669.18 Million |
7022
APURE
3521
AIE
ERRIA
ANSALHSG